7 July 2003
Futura Medical plc announces intention to float on AIM
Futura Medical plc ("the Company"), the pharmaceutical and medical device group that develops innovative products for the sexual healthcare market, is planning to seek admission ("Admission") to the Alternative Investment Market (AIM) of the London Stock Exchange. Dealings are expected to commence this month.
The Company has commitments for an additional £1.7 million of funding to be injected at the time of Admission by the issue of 2,428,571 new ordinary shares of 0.2 pence each at a price of 70 pence per share.
The additional funding is subject to the agreement of shareholders being given at the Company's Annual General Meeting due to be held on 14 July 2003, and Admission taking place by no later than 15 August 2003.